Horizontal bone grafting using equine-derived cancellous bone blocks is associated with severe complications: A prospective clinical and histological pilot study. by Angermair, Johannes et al.
Clin Oral Impl Res. 2020;31:1149–1158.    |  1149wileyonlinelibrary.com/journal/clr
 
Received: 11 February 2020  |  Revised: 30 July 2020  |  Accepted: 21 August 2020
DOI: 10.1111/clr.13661  
O R I G I N A L  R E S E A R C H
Horizontal bone grafting using equine-derived cancellous bone 
blocks is associated with severe complications: A prospective 
clinical and histological pilot study
Johannes Angermair1  |   Dieter D. Bosshardt2,3 |   Katja Nelson1 |   Tabea V. Flügge1  |   
Andres Stricker1,4 |   Tobias Fretwurst1
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction 
in any medium, provided the original work is properly cited and is not used for commercial purposes.
© 2020 The Authors. Clinical Oral Implants Research published by John Wiley & Sons Ltd
Andres Stricker and Tobias Fretwurst contributed equally  
1Clinic of Oral- and Maxillofacial Surgery, 
Translational Implantology, Medical Center 
Freiburg – Faculty of Medicine, University of 
Freiburg, Freiburg, Germany
2Robert K. Schenk Laboratory of Oral 
Histology, School of Dental Medicine, 
University of Bern, Bern, Switzerland
3Department of Periodontology, School of 
Dental Medicine, University of Bern, Bern, 
Switzerland
4Center of Implantology, Periodontology and 
3D Head-and-Neck Imaging Lake Constance, 
Konstanz, Germany
Correspondence
Tobias Fretwurst, Department of Oral- 
and Maxillofacial Surgery, Translational 
Implantology, University Medical Center of 
Freiburg, Freiburg, Germany.
Email: tobias.fretwurst@uniklinik-freiburg.de
Funding information
Geistlich Pharma AG
Abstract
Aims: The aim of this prospective, clinical study was to evaluate the clinical perfor-
mance and histological outcome of a new equine hydroxyapatite collagenated bone 
block (eHAC) for horizontal bone grafting prior to implant placement.
Materials and Methods: Five patients (two male/three female) with a mean age of 
51.6 years (range 22–66 years) and a reduced horizontal bone width of the alveolar 
ridge (mean 3.5 mm) underwent horizontal bone grafting using eHAC at 10 grafting 
sites. Reentry was performed 6.9 months after the horizontal grafting procedure. 
Clinical follow-up (mean 28.9 month) considered width gain of the alveolar ridge, soft 
tissue healing, and complications. To evaluate graft incorporation, four additional pa-
tients underwent histological assessment of equine blocks adjacent to autologous 
blocks 3 and 6 months after grafting.
Results: The study was terminated after graft failure was observed in four of five 
patients. Mean horizontal bone width had increased by 3.6 ± 1.22 mm. Three out of 
nine implants placed had to be removed due to graft failure. Histological evaluation 
revealed large amounts of soft connective tissue within the grafts (mean 67.3 ± 9.5%). 
The proportion of new bone formation 3 months after the lateral grafting procedure 
revealed an average of 8.6%, compared to 11.4% after 6 to 7 months.
Conclusion: Lateral ridge grafting using eHAC achieved measurable horizontal width 
gain but revealed high rates of severe complications.
Clinical Implications: Within the limitations of this study, eHAC bone blocks cannot 
be recommended for horizontal bone grafting.
K E Y W O R D S
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1  | INTRODUC TION
To achieve long-term implant stability, a sufficient alveolar bone 
volume is mandatory. In atrophic jaws, vertical and horizontal 
bone grafting procedures are required prior to implant placement 
to enable an adequate three-dimensional implant position (Sanz 
& Vignoletti, 2015). Autologous bone is still considered to be the 
gold standard in alveolar defects > 5 mm because of its transplant 
competence, mainly used as block grafts (Fretwurst, Gad, Nelson, 
& Schmelzeisen, 2015; Fretwurst, Nack, et al., 2015; Fretwurst, 
Wanner, et al., 2015; Jensen & Terheyden, 2009; Sanz-Sanchez, 
Ortiz-Vigon, Sanz-Martin, Figuero, & Sanz, 2015). However, a 
disadvantage is the associated donor site morbidity (Cordaro, 
Torsello, Miuccio, di Torresanto, & Eliopoulos, 2011; Cremonini, 
Dumas, Pannuti, Lima, & Cavalcanti, 2010; Fretwurst, Nack, 
et al., 2015; Fretwurst, Wanner, et al., 2015; Nkenke et al., 2002; 
Nkenke, Schultze-Mosgau, Radespiel-Troger, Kloss, & Neukam, 
2001). Therefore, allogeneic and xenogeneic bone substitutes are 
considered for clinical application. Xenogeneic grafts are primarily 
of bovine, porcine, or equine origin. In implant dentistry, equine 
hydroxyapatite collagenated cancellous bone blocks containing 
endogenous collagen type I and III (eHAC; Bio-Graft™, Geistlich 
Pharma AG) and equine femur bone (Osteoplant®, OsteOXenon, 
Bioteck), an enzyme deantigenized cortical and/or cancellous bone 
block with a preserved type I collagen component are available 
for application. In preclinical studies in rats, dogs and primates 
equine bone blocks demonstrated complication rates of up to 20% 
(soft tissue dehiscences) and a low rate of new bone formation 
(6%) compared to autologous (19%) grafts after 1 month of healing 
(Benic et al., 2016, 2017; Fontana, Rocchietta, Dellavia, Nevins, & 
Simion, 2008; Nevins, Al Hezaimi, Schupbach, Karimbux, & Kim, 
2012; Schwarz et al., 2010; Simion et al., 2009; Zecha et al., 2011).
Four clinical human studies using equine bone blocks 
(Osteoplant® and eHAC) for horizontal bone grafting demonstrated 
a horizontal gain of 3–4 mm (Di Stefano et al., 2009; Ortiz-Vigon 
et al., 2018; Pistilli et al., 2014; Schwarz, Mihatovic, Ghanaati, & 
Becker, 2017). However, in two studies using eHAC bone blocks 
a rate of 70% of soft tissue dehiscence was reported (Schwarz 
et al., 2017), and Ortiz-Vigon et al. (2018) noted an accumulation of 
complications such as soft tissue dehiscences (35.7%) and an high 
incidence of implant loss (30.8%).
Histological evaluation was performed in three clinical stud-
ies 24 to 26 weeks after horizontal bone grafting (Di Stefano 
et al., 2009; Ortiz-Vigon, Martinez-Villa, Suarez, Vignoletti, & Sanz, 
2017; Schwarz et al., 2017). Using vertical core biopsies, Schwarz 
et al. found remnants of eHAC in 3 of 8 biopsies but histomorpho-
metric evaluation was not performed. Ortiz-Vigon et al. (2017) also 
performed vertical biopsies of the grafted alveolar regions in 13 
patients and revealed a mean of 26.9% of vital bone and 24.4% of 
eHAC remnants. However, vertical biopsies retrieved at the site of 
implant placement usually include residual alveolar bone and parts 
of the block graft and therefore may not allow a full evaluation of 
the block revascularization. Only Di Stefano et al. used a horizontal 
technique to harvest 5 biopsies after horizontal bone grafting with 
an Osteoplant® bone block and a titanium reinforced, expanded 
polytetrafluoroethylene membrane (W.L. Gore & Associates®). The 
authors demonstrated 35% newly formed bone and 30% residual 
grafting material (Di Stefano et al., 2009).
There is a lack of data concerning the clinical performance and 
histological outcome of eHAC for horizontal bone grafting in human 
alveolar bone defects. Therefore, the aim of the present prospective 
clinical study was to evaluate the clinical performance and histolog-
ical outcome of eHAC for horizontal bone grafting using horizontal 
biopsies.
2  | MATERIAL AND METHODS
2.1 | Study design
This study was designed as a prospective clinical pilot study, to as-
sess the performance of eHAC bone grafts (Bio-Graft™, Geistlich 
Pharma AG) for horizontal bone grafting prior to implant place-
ment. The study was conducted at two centers, Department of 
Oral and Maxillofacial Surgery, University of Freiburg and the 
Center of Implantology, Periodontology and 3D Head-and-Neck 
Imaging Lake Constance. The number of patients planned to in-
clude was 16. All patients were treated in accordance with the 
Helsinki Declaration of 1964, as revised in 2013. All patients had 
to sign an informed consent statement. The study was approved 
by the ethics committee of the University medical center of 
Freiburg (no. 503/13). The clinical procedure and monitoring pro-
tocol was examined and confirmed following the GCP guidelines 
(ISO 14155:2011) and STROBE criteria (see Appendix S1). The 
study recruitment phase was 12 months starting from February 
2014 to February 2015. Follow-up was performed until 2019. A 
graft failure rate > 30% was defined as termination criterion in the 
study protocol.
2.2 | Patient sample
Patients with lateral ridge defects were included in the study. 
Inclusion criteria were as follows: a minimum age of 18 years and 
defined defects for horizontal bone augmentation with sufficient 
bone height but insufficient alveolar bone width at the recipient site 
for implant placement and a healthy attached oral mucosa of at least 
3 mm height.
Exclusion criteria comprised general prohibitive conditions for 
dental and/or surgical treatments, including thin mucosa biotype 
(<1 mm), diabetes, a history of malignancies requiring chemotherapy 
or radiotherapy within the past 5 years, radiotherapy of head and 
neck area, immunosuppressive and antiresorptive therapy. Smokers, 
pregnant, or lactating women and patients who participated in an 
investigational device, drug, or biologics study within the 24 weeks 
prior to the start of the study were also excluded.
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2.3 | Surgical phase, follow-up, and clinical 
measurements
Bone grafting was performed in local anesthesia with UDS forte (Sanofi 
Aventis) using a crestal incision with a vertical releasing incision distally 
if necessary to elevate a full-thickness flap. After inspection of the alve-
olar defect, the recipient bone was preconditioned by perforation and 
decortication. The eHAC blocks were trimmed, adjusted to the defect 
size and after predrilling, fixated with recommended osteosynthesis 
screws (Osteosynthesis screws, Geistlich Pharma AG).
Contouring of the graft using deproteinized bovine bone mineral 
DBBM (BioOss®, Geistlich Pharma AG) was performed as a resorp-
tion protection of the cancellous equine grafts as described for bone 
grafting procedures with bone blocks from the iliac crest (Wiltfang 
et al., 2014). The graft was covered with a resorbable collagen mem-
brane (Bio-Gide®, Geistlich Pharma AG).
Periosteal releasing incisions were performed to accomplish a 
tension-free closure using absorbable continuous sutures (Monocryl 
5-0, Ethicon). Standard post-surgical medication, consisting of 
600 mg of Ibuprofen (2/d) and either 750 mg of amoxicillin (3/d) 
or clindamycin 600 mg (3/d), was prescribed. Suture removal was 
scheduled after 2 weeks.
Photo documentation and assessment of the alveolar ridge 
width were measured before and after surgical augmentation and 
during reentry using a caliper and a periodontal probe at defined 
points which were chosen in relation to the adjacent teeth in order 
to ensure reproducibility. Clinical inspection was performed due to 
a standardized follow-up protocol: 1, 14 days, 4 and 13 weeks after 
augmentation. At reentry, 7 months after grafting procedure implant 
placement was performed.
Clinical performance of the equine grafts was described. 
Complications such as infections or pain and presence of soft tissue 
dehiscences as well as removal of graft or implants were documented.
2.4 | Histological analysis
Four additional patients received lateral alveolar crest grafting using 
eHAC adjacent to autologous blocks for histological assessment.
Histological biopsies were harvested 3 to 7 months (2 samples after 
3 months, 3 samples after 6 months, and one sample after 7 months) 
after grafting using horizontal trephines with a diameter of 1.7 mm 
(Helmut Zepf GmbH) (Figure 1). In total, six biopsies were retrieved. All 
biopsies were fixed in 4% formalin for 7 days and stepwise dehydrated 
in an ascending solution of ethanol (70%, 80%, 90%,100%), remain-
ing in each concentration for 24 hr. Specimens were then degreased 
in xylene (Merck) for 1 day, infiltrated, embedded, and polymerized 
in methylmethacrylate (Merck) (Richardson, Jarett, & Finke, 1960). 
Using a precision cutting machine Secotom 50 (Struers), samples were 
sliced in 600 µm sections and mounted onto acrylic slides (Maertin). 
Sections were then ground to a thickness of 100 µm using a rotating 
grinding plate (Struers). Staining was performed with pararosaniline 
(Sigma, Merck) and azure II (Merck) (Jeno & Geza, 1975). For imaging, 
an Axio Imager M1 microscope equipped with a digital AxioCam HRc 
(Carl Zeiss) was used. Samples were histomorphometrically evaluated. 
Relative proportions of bone, biomaterial, and connective tissue were 
identified and quantitatively evaluated using the imaging software for 
Life Science Microscopy analySIS (OLYMPUS EUROPA GmbH). The 
amount of mineralized and non-mineralized structures within the 
graft was assessed. The mineralized structure was further divided into 
graft components and newly formed bone.
2.5 | Statistical analysis
The software package (IBM SPSS Statistics 21.0; IBM Corporation) 
was used for the descriptive analysis. The variables graft survival, 
implant survival, and bone volume changes were analyzed. A de-
pendent t test was performed for parametrically distributed data, 
while a Wilcoxon test was applied for nonparametrically distributed 
data. The significance level was set at p ≤ .05.
3  | RESULTS
3.1 | Clinical performance
Five patients (two males/three females) with a mean age of 
51.6 years (range 22–66 years) and a reduced horizontal bone height 
of the alveolar ridge (mean 3.5 mm) underwent horizontal bone 
grafting using eHAC at 10 grafting sites. Every eligible patient asked 
to participate and agreed to participate in the study. Patient data 
are summarized in Table 1. For histological analysis, four additional 
patients received horizontal bone grafting using eHAC mesial and/
or distal to an autologous bone block graft. Recruitment was termi-
nated after 30% of the grafts failed.
F I G U R E  1   Horizontal histological 
biopsies. Lateral alveolar crest grafting 
was performed with eHAC adjacent to 
autologous bone grafts (a). Horizontal 
sample harvesting was performed 
with a trephine 3 and 6 months after 
grafting (b). Notice the resorbed eHAC 
graft in comparison to the autologous 
grafts
(a) (b)
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During the grafting procedure, the surgical handling of the 
equine bone blocks demonstrated initial problems, as seven blocks 
in four patients cracked during fixation using the recommended 
osteosynthesis screws. These grafts where not placed and new 
eHACs were fixed. Before grafting, the alveolar crest showed a 
horizontal ridge width of 3.5 ± 0.7 mm (Table 2). All grafting pro-
cedures were completed successfully. None of the five patients re-
ported pain after the surgery and no signs of inflammation or soft 
tissue dehiscences were assessed during follow-up. All patients 
continued the follow-up until scheduled reentry after 6.9 months 
(range 6–7 months).
At reentry, 9 of 10 sites showed sufficient alveolar ridge 
width for implant placement. One graft demonstrated insuffi-
cient stability and had to be removed. In this patient, a second 
grafting procedure using an autologous bone block lead to suc-
cessful implant placement after 3 months. The mean ridge width 
at implant placement was 7.1 ± 0.9 mm, leading to a mean hor-
izontal width increase of 3.6 ± 1.2 mm. In total, nine implants 
(Camlog, Straumann, BioMed) were placed in four of five patients 
(Table 1).
After implant placement, no further graft or implant was lost 
until prosthetic loading.
3.2 | Complications
6 of 10 grafting sites (60% of all grafts) failed, and three out of nine 
implants had to be removed (33% implant failure rate).
In one patient, 8 months after prosthetic rehabilitation 
(18 months after grafting) a sequester occurred at the site of grafting 
(Figure 2). Three grafting sites demonstrated graft exposure 10 and 
13 months after grafting resulting in the removal of the grafts to-
gether with the implants. Only one patient demonstrated no grafting 
or implant failure within the observation period of 56 months after 
grafting (Figure 3).
3.3 | Histological analysis
3.3.1 | Native equine bone block prior to grafting
The low power magnification depicts trabecular bone structures in 
the equine bone blocks prior to grafting (Figure 4a). At higher mag-
nification, the analyzed equine bone blocks showed organic material 
consisting of cells and cell debris that varied in type and number. 
Remnants of osteocytes and adipocytes in many intertrabecular 
segments of the sample were detectable (Figure 4b, c).
3.3.2 | Histomorphometry 3–6 months 
after grafting
Histological and histomorphometric evaluation revealed large 
proportions of non-differentiated dense fibrous tissue with high 
amounts of lymphocytes 3 months after grafting (Figure 5a, b). 
Islands of new bone formation on the trabeculae were visible. The 
TA B L E  1   Patients data and overview of complications
Patient Gender Age [years]
Grafting site 
[region]
Reentry 
[months] Implant type Complications
Complication 
[monthsa ]
Last follow-up 
[monthsa ]
1 F 59 45, 46
36
7
7
2 × Camlog 
RootLine ∅ 
3.8 × 11 mm
Removal of graft 
and implants
10 34
Camlog 
ScrewLine ∅ 
3.8 × 9 mm
– – 34
2 F 48 11 7 Straumann BL ∅ 
4.1 × 10 mm
Removal of graft 
and implant
13 22
3 F 63 36
46, 47
7
7
BioMet 3i BOPT 
∅ 4.0 × 10 mm
Soft tissue 
dehiscence
9 19
2 × BioMet 
3i BOPT ∅ 
4.0 × 10 mm
Soft tissue 
dehiscence
Removal of graft
9
18
19
4 M 22 44, 45 6 2 × Camlog 
ScrewLine ∅ 
3.8 × 11 mm
– – 56
5 M 66 35 7 - Removal of graft 7 18
5 patients 2 M, 3 F ∅ 51.6 years 10 grafting sites ∅ 6.9 months 9 implants placed 
6 successful, 3 
removed
60% graft failure ∅ 11 months ∅ 28.9 months
Note: The study was terminated after graft failure in 60% of the grafted sites and removal of three implants (33%).
aMonths after grafting. 
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mean amount of new bone formation was 8.6% (range: 4%–13%) 
after 3 months (Table 3). Adjacent to the trabeculae surface multinu-
cleated cells were detectable (Figure 5c).
After 6 months, differentiated bone marrow with vessels and ad-
ipocytes (Figure 6) was visible, with new bone formation adjacent 
to the trabecular surface (mean new bone formation 11.6%, range: 
1.6%–22%) and howship lacunae on the bone surface (Figure 6b). 
However, two samples demonstrated minimal new bone formation 
even after 6 months (Figure 6d, e). In all samples, new bone formation 
is initiated from the residual alveolar ridge and decreases laterally.
4  | DISCUSSION
The present prospective clinical and histomorphometric pilot study 
was conducted to evaluate the clinical applicability and performance 
of eHAC for horizontal bone grafting. The study was terminated 
after graft failure in 80% of the patients and an implant failure rate 
of 33%.
The results are similar to the data of Ortiz-Vigon et al. (2018) 
demonstrating an implant failure rate of 30.8% after eHAC graft-
ing. In contrast to the present study, a high rate of 30% early soft 
tissue dehiscence immediately after grafting was described by Ortiz-
Vigon et al. (2018) and of 70% by Schwarz et al. (2017). Even though 
a high rate of soft tissue dehiscence was reported by Schwarz et al. 
(2017), no graft or implant failure was observed probably due to 
smaller initial defect size and the selected defect configurations, as 
only single tooth gaps were included in comparison with the major 
horizontal defects restored in the study of Ortiz-Vigon et al. (2018) 
and in the present study. The defect configuration in single tooth 
gaps, which is rather self-containing might influence the graft re-
modeling and incorporation (Elnayef et al., 2018). Nevertheless, in 
the study of Schwarz et al. (2017), at implant placement an additional 
grafting procedure, respectively, contour augmentation due to an 
insufficient horizontal ridge was indicated in 40% of the patients. 
Equine blocks from a different supplier (Osteoplant®, OsteOXenon, 
Bioteck) demonstrated an eHAC-comparable incidence of graft fail-
ures (50%) and implant loss (20%) in a randomized controlled clinical 
trial including 40 patients (autologous bone as control: 0% graft fail-
ures) (Pistilli et al., 2014).
Neglecting the high rate of graft and implant failure of equine 
bone blocks, 7 months after grafting the mean horizontal bone 
volume increased by 3–4 mm. These values are comparable with 
those of intraoral harvested autologous blocks after 6 months 
(3.9 ± 0.38 mm) (Sanz-Sanchez et al., 2015). Although the initial hor-
izontal gain of bone volume after equine block grafting is promis-
ing, long-term data on the stability and resorption properties of the 
equine cancellous bone are lacking. To analyze graft incorporation 
and new bone formation, histological examination of equine grafts 
was performed 3 to 7 months after horizontal bone grafting. In gen-
eral, vertical biopsies are obtained at the implant site which is the 
preferred approach to illustrate the quality of bone at the implant 
surface. However, this does not allow evaluation of the graft remod-
eling. Horizontal biopsies allow a discrimination of graft and residual 
bone and the evaluation of the remodeling throughout the complete 
graft. If the biopsy remains in the trephine bur, the sample remains 
intact and allows spatial orientation within the sample. Hence, in the 
present study horizontal trephine biopsies were obtained and histo-
morphometric analysis revealed a trabecular structure of the graft 
with large proportions of soft tissue (69.7%) within the grafted areas 
after 3 months and 66.2% after 6 to 7 months. The mean amount 
of new bone formation was 8.6% after 3 months and 11.4% after 
6 to 7 months. In comparison, Ortiz-Vigon et al. (2017) reported 
47.1 ± 19.2% of soft tissue proportion and 26.9 ± 12.2% of new 
bone formation within the vertical biopsies. As mentioned earlier, 
the mode of biopsy retrieval could influence the amount of bone, as 
Patient
Grafting site 
[region]
Number 
of blocks
Ridge width at 
baseline [mm]
Ridge width at 
reentry [mm]
Gain in ridge 
width [mm]
1 45 2 4 8 4
46 4.5 8 3.5
36 1 4 No measurement -
2 11 1 3 6 3
3 36 1 4 6 2
4 6 2
46 2 4 7 3
47 3 8 5
4 44 1 2 7 5
45 3 8 5
5 35 1 3 Block removal -
10 9 3.5 (SD 0.7) 7.1 (SD 0.9) 3.6 (SD 1.2)
Note: Alveolar crest volume changes were evaluated clinically at reentry. Alveolar ridge width at 
baseline was 3.5 ± 0.7 and 7.1 ± 0.9 mm after grafting. Mean horizontal bone width increased by 
3.6 ± 1.2 mm.
TA B L E  2   Grafting sites and alveolar 
ridge volume
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parts of the residual bone might have been captured within the sam-
ple. Since Schwarz et al. (2017) did not perform histomorphometry, 
no conclusions or comparison can be drawn. In the present study, 
histological evaluation revealed large proportions of non-differen-
tiated dense fibrous tissue with high amounts of lymphocytes and 
isolated multinucleated cells on the trabeculae of the graft after 
3 months. Fibrous ingrowth during the healing process might have 
prevented bone formation in some cases. However, all grafting pro-
cedures were conducted using a cell occlusive collagen membrane 
(Bio-Gide®, Geistlich Pharma AG) as specified in the study protocol. 
Animal studies investigating eHAC bone grafting question the need 
for a barrier membrane to promote bone ingrowth, since no histo-
logical difference concerning new bone formation and graft incor-
poration with and without collagen membranes was demonstrated 
(Simion et al., 2009; Zecha et al., 2011).
A graft failure rate of 60% as demonstrated in the present study is 
unacceptable in daily clinics, as alveolar reconstruction using particu-
late bovine bone and autologous bone as block or shield demonstrates 
low complication rates and long-term stability (Fretwurst, Nack, et al., 
2015; Fretwurst, Wanner, et al., 2015; Troeltzsch et al., 2016). Since 
no soft tissue dehiscences occurred in the present study, possible 
graft failure mechanisms could be attributed to insufficient graft 
F I G U R E  2   Late dehiscence of eHAC after prosthetic restoration. After grafting procedure, implant placement could be performed 
at 7 months (2 × BioMet implants). During further observation, a late dehiscence occurred 18 months after grafting procedure. As a 
consequence, the two grafts were removed
(a) (b) (c)
(d) (e) (f)
F I G U R E  3   Successful lateral alveolar crest grafting using eHAC in a 22-year-old patient. Reentry 6 months after grafting demonstrated 
sufficient alveolar ridge width for implant placement of two implants (2 × Camlog ScrewLine 3.8 × 11 mm). Second stage surgery and 
prosthetic restoration were performed after grafting procedure. The last follow-up was performed 56 months after grafting
(a) (b) (c) (d)
(e) (f) (g) (h)
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incorporation/remodeling due to a low transplant competence (poor 
osteoconductive properties), graft infection after implant placement 
and/or remaining equine cell and protein content with a possible 
corresponding immunogenic potential. The latter is supported by 
histological evaluation of native blocks prior grafting which revealed 
organic material such as cells and cell debris within the graft trabec-
ulae (Figure 4). Interestingly, a current review summarizing the litera-
ture of allogeneic, cancellous bone blocks for vertical bone grafting 
F I G U R E  4   Histological section of an 
equine block prior grafting (staining azure 
2 and pararosaniline). (a) Overall view. (b) 
magnification ×100 (arrows indicating 
adipocytes). (c) magnification ×400 
(arrows indicating osteocytes)
(a)
(b) (c)
F I G U R E  5   Histological analysis of 
an equine block 3 months after grafting 
(staining azure 2 and pararosaniline). 
(a) Overall view. (b) Non-differentiated 
dense fibrous tissue with high amounts of 
lymphocytes adjacent to the trabeculae. 
(c) Arrow is indicating a multinucleated 
cell
(a)
(b) (c)
Patient
Biopsy 
[region]
Reentry 
[months]
Soft tissue 
[%]
Mineralized 
fraction [%]
eHAC 
[%]
New bone 
formation [%]
6 35 3 66.5 33.5 29.1 4.4
7 13 3 72.8 27.2 14.4 12.8
23 basal 6 62 38 24.2 13.8
23 coronal 6 78.4 21.6 13.3 8.3
8 24 6 72.6 27.4 25.8 1.6
9 17 7 51.8 48.2 26.4 21.8
Note: Six biopsies were harvested after 3 to 7 months. After histological preparation, 
histomorphometric evaluation was performed. The biopsies showed high proportions of soft tissue 
(mean 67.3 ± 9.5%). New bone formation was 8.6% at 3 months and 11.4% at 6 to 7 months.
TA B L E  3   Histomorphometric analysis 
of the biopsies
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reported severe complications with similar delayed graft and implant 
loss after implant placement and prosthetic loading like in the present 
study, which makes a similar failure mechanism conceivable (Draenert, 
Kammerer, Berthold, & Neff, 2016). An immunological reaction to 
major histocompatibility complex molecules of remaining cells has not 
been described for equine grafting materials yet. Although it is known 
that horse gene sequences showed homology to DNA sequences in 
the human genome, the impact of remaining cells and proteins on 
host immune response or induction of a foreign body reaction has not 
been examined (Tozaki et al., 2007). Processing of equine bone blocks 
is based on hydrolytic enzymes to dissolve and eliminate immuno-
genic components such as cells, proteins, and lipids from the tissue 
and preserve bone cell adhesion and remodeling properties (Cusinato 
et al., 2016). However, the mechanism for the late failure of the equine 
bone grafts and the small rate of new bone formation is still unclear 
and could be investigated with regard to the immunogenic and archi-
tectural properties of the blocks in future studies.
4.1 | Limitations
The conclusions of this prospective clinical and histological study 
are limited due to the lack of a control group and a small sample 
population. This arises from ethical considerations to terminate the 
study after a high rate of late graft failures.
5  | CONCLUSION
The clinical application of eHAC for horizontal bone grafting re-
vealed a high occurrence of complications including late soft tissue 
dehiscences, graft failure, and implant loss. Within the limitations of 
this study, eHAC bone blocks cannot be recommended for horizon-
tal bone grafting.
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Dense soft tissue and minimal new bone 
formation originating from the residual 
alveolar bone (arrows)
(a)
(b)
(d)
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